NsGene
closedNsGene develops products for the treatment of neurological, alzheimer’s, and parkinson's disease and sensorineural hearing loss.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD28—42m (Dealroom.co estimates May 2005.)
Company register number 21479195
Ballerup Capital Region of Denmark (HQ)
Authorizing premium user...